An experimental lung disease drug developed using artificial intelligence showed promise in reversing biological signs of aging, according to its developer Insilico.
Longevity enthusiasts have long embraced the repurposing of existing medications to delay aging. Read more:
📷: Lam Yik/Bloomberg